MiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference
December 07, 2020 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Dec. 07, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...
MiMedx Appoints Jack Howarth as Senior Vice President, Investor Relations
December 01, 2020 09:22 ET
|
MiMedx Group, Inc
Experienced Healthcare Executive Will Expand Company’s Visibility Within the Financial Community MARIETTA, Ga., Dec. 01, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ: MDXG) (“MiMedx” or the...
MiMedx To Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 24, 2020 17:15 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Nov. 24, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...
MiMedx To Host Virtual 2020 Annual Meeting of Shareholders on Friday, November 20
November 13, 2020 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Nov. 13, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...
MiMedx To Present At Canaccord Genuity Virtual MedTech & Diagnostics Forum
November 12, 2020 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Nov. 12, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...
MiMedx Announces Third Quarter 2020 Financial Results
November 04, 2020 16:07 ET
|
MiMedx Group, Inc
Third Quarter Net Sales of $64.3 Million, Above Preliminary Range Common Stock Relisted on The Nasdaq Stock Market Under the Ticker Symbol “MDXG” Company to Host Conference Call...
MiMedx To Advance the Conversation of Study Bias in the Clinical Evaluation of Skin Substitutes in Chronic Wounds at SAWC FALL
November 04, 2020 08:00 ET
|
MiMedx Group, Inc
Company to Showcase Newly Launched EpiCord Expandable Product Line MARIETTA, Ga., Nov. 04, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ: MDXG) (“MiMedx” or “the Company”), an industry leader...
MiMedx Shares to Commence Trading on Nasdaq on Wednesday, November 4, 2020
November 03, 2020 17:30 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Nov. 03, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...
MiMedx Announces Largest U.S. Commercial Payor Will Provide Coverage for EpiFix in the Treatment of Diabetic Foot Ulcers
November 03, 2020 08:00 ET
|
MiMedx Group, Inc
Only Amniotic Product Covered Under Updated Commercial Policy MARIETTA, Ga., Nov. 03, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an industry leader...
MiMedx Announces Relisting on Nasdaq
October 30, 2020 16:52 ET
|
MiMedx Group, Inc
MARIETTA, Ga., Oct. 30, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today...